8-K: Eureka Acquisition Corp Secures Business Combination Deadline Extension Until August 2025, Options for Further Extensions

Eureka Acquisition Corp has amended its trust agreement to extend the deadline for completing a business combination by one month to August 3, 2025, with options for up to 12 additional monthly extensions until July 3, 2026.

Summary

• Eureka Acquisition Corp (the Company) entered into an amendment to its trust agreement on June 30, 2025.
• Shareholders approved amending the company's Second Amended and Restated Memorandum and Articles of Association to extend the business combination deadline.
• The Company now has until July 3, 2025, to complete a business combination, with the option to extend this period up to 12 times, each by an additional one month, for a total of up to 12 months, reaching July 3, 2026.
• Each monthly extension requires a deposit of $150,000 (Monthly Extension Fee) into the company's trust account.
• A $150,000 Monthly Extension Fee was deposited into the trust account on or about July 2, 2025, extending the deadline from July 3, 2025, to August 3, 2025.
• This payment was made by the Company from its working capital.
• Failure to pay the Monthly Extension Fee within a 30-day Cure Period will result in immediate cessation of operations, winding up, liquidation, and dissolution.

Sentiment

Score: 5

Explanation: The extension provides more time, which is positive for the company's survival, but the need for an extension and the associated costs indicate a lack of progress on a business combination, balancing the sentiment to neutral.

Positives

• The Company secured an extension of its deadline to complete a business combination, providing more time to identify and finalize a suitable target.
• Shareholders approved the extension mechanism, indicating support for the company's continued efforts.
• The initial $150,000 extension fee has been paid, ensuring the first month's extension.

Negatives

• The Company requires an extension, indicating it has not yet identified or completed a business combination within its initial timeframe.
• Each monthly extension incurs a $150,000 fee, which will deplete the company's working capital over time if multiple extensions are utilized.
• Failure to pay the monthly extension fee within the cure period will lead to immediate liquidation, posing a significant risk.

Risks

• Failure to complete a business combination by the extended deadline of July 3, 2026, or earlier if extensions are not utilized.
• Inability to make the required $150,000 Monthly Extension Fee payments, leading to immediate cessation of operations, winding up, and liquidation.
• Depletion of working capital due to recurring Monthly Extension Fees, potentially impacting the company's ability to fund operations or a business combination.
• Risk of liquidation and dissolution if the Company fails to make any applicable past due payment during the 30-day Cure Period.

Future Outlook

The Company has secured the ability to extend its business combination deadline for up to 12 additional months, until July 3, 2026, provided it continues to make monthly payments of $150,000. Failure to make these payments will result in liquidation.

Management Comments

• The Company has until July 3, 2025 to complete a business combination, and may elect to extend the period to consummate a business combination up to 12 times, each by an additional one-month extension... for a total of up to 12 months to July 3, 2026.
• The payment of the Monthly Extension Fee was made by the Company from its working capital.

Industry Context

SPACs frequently seek extensions to their business combination deadlines, especially in challenging market conditions or when struggling to identify a suitable target. This filing aligns with a common trend in the SPAC market where companies require additional time beyond their initial de-SPAC period. The structure of monthly payments for extensions is also a common mechanism.

Comparison to Industry Standards

• The practice of extending the business combination deadline is common among SPACs that have not yet identified or completed a merger, similar to other SPACs like Gores Holdings, Churchill Capital, or Pershing Square Tontine Holdings which have also sought or undergone extensions.
• The monthly extension fee of $150,000 is within the typical range for such extensions, which can vary based on the size of the trust and the SPAC's initial offering terms.
• The provision for a "Cure Period" before liquidation for missed payments is a standard protective clause in trust agreements, ensuring a brief grace period.

Corporate Governance

Stakeholder Impact

• Shareholders: Public shareholders' funds in the trust account are protected by the extension fees, but the delay in finding a business combination introduces prolonged uncertainty and potential dilution if a deal is eventually found. Failure to complete a deal or pay fees would lead to liquidation and return of trust funds.
• Management: Gains additional time to execute on the company's mandate to find a business combination, but faces ongoing pressure to secure a deal and manage working capital for extension fees.

Next Steps

• Identify and complete an initial business combination.
• Potentially elect for further monthly extensions by depositing $150,000 for each additional month.
• Ensure timely payment of Monthly Extension Fees to avoid liquidation.

Key Dates

Keywords

SPAC, Special Purpose Acquisition Company, Eureka Acquisition Corp, EURK, business combination, extension, trust agreement, liquidation, merger, acquisition, Nasdaq, 8-K, corporate governance